Patents by Inventor Seyed Mojtaba Yazdanparast

Seyed Mojtaba Yazdanparast has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preventing cytokine storm in COVID-19 patients by suppressing clonal expansion in activated lymphocytes using alternating electric fields
    Patent number: 11877838
    Abstract: A method for preventing cytokine storm by suppressing clonal expansion of hyperactivated lymphocytes in a COVID-19 infected patient. The method includes placing at least four electrodes on skin of the COVID-19 infected patient by putting at least two electrodes at two locations over chest in front of ribcage of the COVID-19 infected patient and putting at least two other electrodes at two locations adjacent to lung tissue of the COVID-19 infected patient and suppressing mitosis of hyperactivated proliferative lymphocytes cells within the lung tissue of the COVID-19 infected patient by electrically stimulating the hyperactivated proliferative lymphocytes. Electrically stimulating the hyperactivated proliferative lymphocytes includes generating an alternating electric field (AEF) within the lung tissue by applying an AC voltage to the at least four electrodes and periodically changing a direction of the generated AEF in a plurality of directions within the lung tissue.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: January 23, 2024
    Assignee: NANO HESGARSAZAN SALAMAT ARYA
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Hamed Abadijoo, Mahsa Faramarzpour Darzini, Mohammadreza Ghaderinia, Hossein Simaee, Seyed Mojtaba Yazdanparast, Shahriar Shalileh
  • PREVENTING CYTOKINE STORM IN COVID-19 PATIENTS BY SUPPRESSING CLONAL EXPANSION IN ACTIVATED LYMPHOCYTES USING ALTERNATING ELECTRIC FIELDS
    Publication number: 20220202305
    Abstract: A method for preventing cytokine storm by suppressing clonal expansion of hyperactivated lymphocytes in a COVID-19 infected patient. The method includes placing at least four electrodes on skin of the COVID-19 infected patient by putting at least two electrodes at two locations over chest in front of ribcage of the COVID-19 infected patient and putting at least two other electrodes at two locations adjacent to lung tissue of the COVID-19 infected patient and suppressing mitosis of hyperactivated proliferative lymphocytes cells within the lung tissue of the COVID-19 infected patient by electrically stimulating the hyperactivated proliferative lymphocytes. Electrically stimulating the hyperactivated proliferative lymphocytes includes generating an alternating electric field (AEF) within the lung tissue by applying an AC voltage to the at least four electrodes and periodically changing a direction of the generated AEF in a plurality of directions within the lung tissue.
    Type: Application
    Filed: March 18, 2022
    Publication date: June 30, 2022
    Applicant: Nano Hesgarsazan Salamat Arya
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Hamed Abadijoo, Mahsa Faramarzpour Darzini, Mohammadreza Ghaderinia, Hossein Simaee, Seyed Mojtaba Yazdanparast, Shahriar Shalileh